mitomycin has been researched along with Bone Cancer in 38 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Excerpt | Relevance | Reference |
---|---|---|
"Based on the observation of topoisomerase-1, upregulation by mitomycin C (MMC), and the phase I antitumor activity of sequential MMC/irinotecan in esophageal cancer, we conducted a phase II evaluation of two schedules of this combination in previously untreated stage III/IV esophageal/gastroesophageal junction adenocarcinomas." | 9.14 | Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma. ( Abbas, A; Bekaii-Saab, T; Burak, W; Lustberg, MB; Lustberg, ME; McCracken-Bussa, B; Otterson, G; Villalona-Calero, MA; Young, D, 2010) |
"Strontium-89 is an established alternative for the alleviation of bone pain in prostate cancer." | 9.11 | Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study. ( Edgren, M; Ginman, C; Kälkner, KM; Nilsson, S; Nordström, B; Ryberg, M; Strang, P; Westlin, JE; Zimmermann, R, 2005) |
"Twenty-five patients with metastatic breast cancer in progression after prior chemotherapy +/- hormonotherapy were treated with etoposide 50 mg/m2 i." | 7.67 | Etoposide and mitomycin-C in pretreated metastatic breast cancer. ( Cellerino, R; Menichetti, ET; Miseria, S; Silva, RR; Torresi, U; Tummarello, D, 1989) |
"Sixty-two patients with metastatic hormonal refractory adenocarcinoma of the prostate received a combination of doxorubicin, mitomycin-C, and 5-fluorouracil (DMF)." | 7.66 | Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer. ( Grant, C; Johnson, DE; Logothetis, CJ; Ogden, S; Samuels, ML; Trindade, A; von Eschenbach, AC, 1983) |
" The aim was to investigate the therapeutic efficacy and tolerance of mitomycin C (MMC) in combination with gemcitabine (GEM) or capecitabine (CAPE) in previously untreated patients with advanced biliary tract cancer." | 6.71 | Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. ( Depisch, D; Gruenberger, T; Karall, K; Kornek, GV; Laengle, F; Lang, F; Penz, M; Scheithauer, W; Schuell, B, 2004) |
"Based on the observation of topoisomerase-1, upregulation by mitomycin C (MMC), and the phase I antitumor activity of sequential MMC/irinotecan in esophageal cancer, we conducted a phase II evaluation of two schedules of this combination in previously untreated stage III/IV esophageal/gastroesophageal junction adenocarcinomas." | 5.14 | Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma. ( Abbas, A; Bekaii-Saab, T; Burak, W; Lustberg, MB; Lustberg, ME; McCracken-Bussa, B; Otterson, G; Villalona-Calero, MA; Young, D, 2010) |
"Strontium-89 is an established alternative for the alleviation of bone pain in prostate cancer." | 5.11 | Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study. ( Edgren, M; Ginman, C; Kälkner, KM; Nilsson, S; Nordström, B; Ryberg, M; Strang, P; Westlin, JE; Zimmermann, R, 2005) |
"The aim of this study was to compare the treatment efficacy of mitomycin-C plus tamoxifen (MT) to adriamycin, dibromodulcitol and tamoxifen (DAT) in previously treated patients with metastatic breast cancer." | 5.05 | A pilot study of mitomycin-C and tamoxifen (MT) versus dibromodulcitol, adriamycin, and tamoxifen (DAT). ( Chang, YC; Crowley, J; Falkson, G; Tormey, DC, 1982) |
"Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
"Twenty-five patients with metastatic breast cancer in progression after prior chemotherapy +/- hormonotherapy were treated with etoposide 50 mg/m2 i." | 3.67 | Etoposide and mitomycin-C in pretreated metastatic breast cancer. ( Cellerino, R; Menichetti, ET; Miseria, S; Silva, RR; Torresi, U; Tummarello, D, 1989) |
"Sixty-two patients with metastatic hormonal refractory adenocarcinoma of the prostate received a combination of doxorubicin, mitomycin-C, and 5-fluorouracil (DMF)." | 3.66 | Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer. ( Grant, C; Johnson, DE; Logothetis, CJ; Ogden, S; Samuels, ML; Trindade, A; von Eschenbach, AC, 1983) |
" The aim was to investigate the therapeutic efficacy and tolerance of mitomycin C (MMC) in combination with gemcitabine (GEM) or capecitabine (CAPE) in previously untreated patients with advanced biliary tract cancer." | 2.71 | Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. ( Depisch, D; Gruenberger, T; Karall, K; Kornek, GV; Laengle, F; Lang, F; Penz, M; Scheithauer, W; Schuell, B, 2004) |
"Stage IV squamous cell carcinoma of the anus outcomes are poor, but first-line chemotherapy can enable good response rates." | 1.46 | Multimodal Therapy of Squamous Cell Carcinoma of the Anus With Distant Metastasis: A Single-Institution Experience. ( Benezery, K; Cavaglione, G; Doyen, J; Evesque, L; Follana, P; François, E; Reure, J; Tuan Falk, A, 2017) |
"Osteosarcoma is the most common malignant bone tumor in children and young people." | 1.38 | Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study. ( Kallis, C; Strauss, SJ; Whelan, JS; Windsor, RE; Wood, NE, 2012) |
"When treated with mitomycin C, p53-deficient cells, but not p53-expressing cells, showed a marked increase in ceramide levels." | 1.38 | DNA damage induces down-regulation of UDP-glucose ceramide glucosyltransferase, increases ceramide levels and triggers apoptosis in p53-deficient cancer cells. ( Duerksen-Hughes, PJ; Filippov, V; Filippova, M; Haynes, TA; Yang, J; Zhang, K, 2012) |
"We experienced 522 patients with breast carcinoma and 14 cases (2." | 1.29 | [A case resectable hepatic metastases of breast cancer following intrahepatic arterial chemotherapy]. ( Matsumine, T; Matsumoto, J; Minami, T; Takami, M; Takanishi, K, 1996) |
" In the present study we have evaluated the therapeutic efficacy of pamidronate (3-amino-1-hydroxypropylidene-1,1-bisphosphonic acid) combined with mitomycin C (MMC) on bone metastasis of breast cancer using an animal model." | 1.29 | Therapeutic efficacy of pamidronate in combination with chemotherapy to bone metastasis of breast cancer in a rat model. ( Enomoto, K; Ikeda, T; Ishii, S; Kitajima, M; Tamura, H; Wada, N, 1996) |
"Reported is the case of a hepatocellular carcinoma with a complete remission of the bone metastasis by arterial chemotherapy." | 1.28 | [Hepatocellular carcinoma with a complete remission of bone metastasis achieved by arterial chemotherapy]. ( Aoki, Y; Fujimoto, T; Fukushima, H; Hirai, K; Iwai, I; Majima, Y; Nakashima, O; Shimada, M; Tanaka, M; Yamashita, K, 1990) |
"A 35-year-old woman tuffering from gastric cancer associated with disseminated carcinomatosis of the bone marrow is reported." | 1.27 | [Effective postoperative chemotherapy of gastric cancer associated with disseminated carcinomatosis of the bone marrow]. ( Akimoto, R; Asano, E; Higashino, Y; Kato, M; Mukawa, A; Nagakawa, T; Nakamura, T; Uchida, H, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (39.47) | 18.7374 |
1990's | 12 (31.58) | 18.2507 |
2000's | 4 (10.53) | 29.6817 |
2010's | 5 (13.16) | 24.3611 |
2020's | 2 (5.26) | 2.80 |
Authors | Studies |
---|---|
Frost, MG | 1 |
Mazloumi Aboukheili, AM | 1 |
Toth, R | 1 |
Walden, H | 1 |
Evesque, L | 1 |
Benezery, K | 1 |
Follana, P | 1 |
Tuan Falk, A | 1 |
Doyen, J | 1 |
Reure, J | 1 |
Cavaglione, G | 1 |
François, E | 1 |
Oashi, K | 1 |
Tsutsumida, A | 1 |
Namikawa, K | 1 |
Tanaka, R | 1 |
Omata, W | 1 |
Yamamoto, Y | 1 |
Yamazaki, N | 1 |
Lustberg, MB | 1 |
Bekaii-Saab, T | 1 |
Young, D | 1 |
Otterson, G | 1 |
Burak, W | 1 |
Abbas, A | 1 |
McCracken-Bussa, B | 1 |
Lustberg, ME | 1 |
Villalona-Calero, MA | 1 |
Windsor, RE | 1 |
Strauss, SJ | 1 |
Kallis, C | 1 |
Wood, NE | 1 |
Whelan, JS | 1 |
Haynes, TA | 1 |
Filippov, V | 2 |
Filippova, M | 2 |
Yang, J | 1 |
Zhang, K | 1 |
Duerksen-Hughes, PJ | 2 |
DAWSON, EM | 1 |
Kornek, GV | 1 |
Schuell, B | 1 |
Laengle, F | 1 |
Gruenberger, T | 1 |
Penz, M | 1 |
Karall, K | 1 |
Depisch, D | 1 |
Lang, F | 1 |
Scheithauer, W | 1 |
Nilsson, S | 1 |
Strang, P | 1 |
Ginman, C | 1 |
Zimmermann, R | 1 |
Edgren, M | 1 |
Nordström, B | 1 |
Ryberg, M | 1 |
Kälkner, KM | 1 |
Westlin, JE | 1 |
Takeuchi, S | 1 |
Akahoshi, Y | 1 |
Kasai, C | 1 |
Nishimoto, Y | 1 |
Logothetis, CJ | 1 |
Samuels, ML | 1 |
von Eschenbach, AC | 1 |
Trindade, A | 1 |
Ogden, S | 1 |
Grant, C | 1 |
Johnson, DE | 1 |
van Oosterom, AT | 1 |
Powles, TJ | 1 |
Hamersma, E | 1 |
Smith, IE | 1 |
Engelsman, E | 1 |
Chang, YC | 1 |
Falkson, G | 1 |
Tormey, DC | 1 |
Crowley, J | 1 |
Moriyama, A | 1 |
Murata, I | 1 |
Kuroda, T | 1 |
Yoshikawa, I | 1 |
Tabaru, A | 1 |
Ogami, Y | 1 |
Otsuki, M | 1 |
Kakinuma, H | 1 |
Sato, K | 1 |
Miura, K | 1 |
Sasaki, S | 1 |
Kato, T | 1 |
Ishikawa, A | 1 |
Matsuura, M | 1 |
Nakajima, N | 1 |
Ozawa, M | 1 |
Matsuda, M | 1 |
Ito, K | 1 |
Suzuki, K | 1 |
Toyama, K | 1 |
Yumoto, Y | 2 |
Okuda, T | 2 |
Shimizu, S | 1 |
Kawase, K | 1 |
Matsumoto, J | 1 |
Minami, T | 1 |
Takami, M | 1 |
Takanishi, K | 1 |
Matsumine, T | 1 |
Tamura, H | 1 |
Ishii, S | 1 |
Ikeda, T | 1 |
Wada, N | 1 |
Enomoto, K | 1 |
Kitajima, M | 1 |
Oura, S | 1 |
Sakurai, T | 1 |
Yoshimura, G | 1 |
Tamaki, T | 1 |
Umemura, T | 1 |
Kokawa, Y | 1 |
Liu, C | 1 |
Dai, G | 1 |
Zhang, X | 1 |
Kokufu, I | 1 |
Taniguchi, H | 1 |
Kim, YH | 1 |
Fukuda, K | 1 |
Yamamoto, M | 1 |
Yano, T | 1 |
Yamada, K | 1 |
Kitano, H | 1 |
Huang, TG | 1 |
Ip, SM | 1 |
Yeung, WS | 1 |
Ngan, HY | 1 |
Zeng, J | 1 |
Hu, Y | 1 |
Pei, F | 1 |
Lei, S | 1 |
Mao, Y | 1 |
Wei, Y | 1 |
Fujii, S | 1 |
Fukushima, H | 1 |
Hirai, K | 1 |
Shimada, M | 1 |
Aoki, Y | 1 |
Iwai, I | 1 |
Yamashita, K | 1 |
Fujimoto, T | 1 |
Tanaka, M | 1 |
Majima, Y | 1 |
Nakashima, O | 1 |
Thomas, G | 1 |
Dembo, A | 1 |
DePetrillo, A | 1 |
Pringle, J | 1 |
Ackerman, I | 1 |
Bryson, P | 1 |
Balogh, J | 1 |
Osborne, R | 1 |
Rosen, B | 1 |
Fyles, A | 1 |
Menichetti, ET | 1 |
Silva, RR | 1 |
Tummarello, D | 1 |
Miseria, S | 1 |
Torresi, U | 1 |
Cellerino, R | 1 |
Inoue, K | 1 |
Horikoshi, N | 1 |
Mukaiyama, T | 1 |
Ogawa, M | 1 |
Kuraishi, Y | 1 |
Adachi, I | 1 |
Suzuki, M | 1 |
Tsuchihashi, T | 1 |
Yamaguchi, K | 1 |
Abe, K | 1 |
Matsumoto, K | 1 |
Sadamoto, Y | 1 |
Haruma, K | 1 |
Tokumo, K | 1 |
Teshima, H | 1 |
Murakami, S | 1 |
Sumii, K | 1 |
Kajiyama, G | 1 |
Yamashita, Y | 1 |
Niimoto, M | 1 |
Hattori, T | 1 |
Kato, Y | 1 |
Tashima, M | 1 |
Sawada, H | 1 |
Yamagishi, M | 1 |
Uchino, H | 1 |
Sulkes, A | 1 |
Gez, E | 1 |
Pfeffer, MR | 1 |
Catane, R | 1 |
Isacson, R | 1 |
Biran, S | 1 |
Higashino, Y | 1 |
Nakamura, T | 1 |
Kato, M | 1 |
Asano, E | 1 |
Akimoto, R | 1 |
Uchida, H | 1 |
Mukawa, A | 1 |
Nagakawa, T | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Phase II Randomized Trial of Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer[NCT00201747] | Phase 2 | 80 participants (Actual) | Interventional | 2001-09-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for mitomycin and Bone Cancer
Article | Year |
---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
[5-Fluorouracil, adriamycin, and mitomycin C (FAM) combination chemotherapy in adenocarcinoma of the parotid gland].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Doxorubicin; | 1989 |
6 trials available for mitomycin and Bone Cancer
Article | Year |
---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Carcin | 2010 |
Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Bo | 2004 |
Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Double-Blind Method; Epirubici | 2005 |
A phase II study of Mitomycin C in refractory adcvanced breast cancer. A multi-centre pilot study.
Topics: Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Mitomycin; Mitomycins; N | 1980 |
A pilot study of mitomycin-C and tamoxifen (MT) versus dibromodulcitol, adriamycin, and tamoxifen (DAT).
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; | 1982 |
31 other studies available for mitomycin and Bone Cancer
Article | Year |
---|---|
Characterization of FANCL variants observed in patient cancer cells.
Topics: Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Bone Neoplasms; Cell Line, Tumor; Cell Surviva | 2020 |
Multimodal Therapy of Squamous Cell Carcinoma of the Anus With Distant Metastasis: A Single-Institution Experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone | 2017 |
Combination chemotherapy for metastatic extramammary Paget disease.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Neopla | 2014 |
Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; | 2012 |
DNA damage induces down-regulation of UDP-glucose ceramide glucosyltransferase, increases ceramide levels and triggers apoptosis in p53-deficient cancer cells.
Topics: Acid Ceramidase; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Ceramides; Colonic Neop | 2012 |
OSTEOGENIC SARCOMA IN CHILDHOOD.
Topics: Adolescent; Bone Neoplasms; Child; Humans; Infant; Methotrexate; Mitomycin; Mitomycins; Neoplasms; O | 1963 |
The early response to DNA damage can lead to activation of alternative splicing activity resulting in CD44 splice pattern changes.
Topics: Alternative Splicing; Antibiotics, Antineoplastic; Bone Neoplasms; Cell Line, Tumor; Colonic Neoplas | 2007 |
[Clinical evaluation on the sensitivity test for anti-cancer agents in malignant bone and soft-tissue tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; | 1984 |
Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Doxorubicin; Drug Ev | 1983 |
Pericardiac metastasis from advanced gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Fluorouracil; Heart Neoplasms; Human | 1995 |
[Chemoembolization with mitomycin C microcapsules (MMC-mc) in the treatment of bone metastases from prostatic and renal cancer].
Topics: Aged; Bone Neoplasms; Capsules; Chemoembolization, Therapeutic; Female; Humans; Kidney Neoplasms; Ma | 1994 |
[Advanced breast cancer with onset of multi-organ metastases successfully treated with combined loco-regional therapies: a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Ch | 1993 |
[FAM as a palliative chemotherapy for gastric cancer with bone metastasis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disseminated Intrava | 1996 |
[A case resectable hepatic metastases of breast cancer following intrahepatic arterial chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Femal | 1996 |
Therapeutic efficacy of pamidronate in combination with chemotherapy to bone metastasis of breast cancer in a rat model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Neoplasms; Diphosphonates; | 1996 |
[Bone metastases responsive to pamidronate therapy in breast cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphonat | 1997 |
[Chemosensitivity test for human osteosarcoma cells].
Topics: Antibiotics, Antineoplastic; Bone Neoplasms; Drug Screening Assays, Antitumor; Epirubicin; Humans; M | 1996 |
[A case of adriamycin and methotrexate-resistant recurrent breast cancer treated with doxifluridine and mitomycin C].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 1999 |
Mitomycin C and cisplatin enhanced the antitumor activity of p53-expressing adenovirus in cervical cancer cells.
Topics: Adenoviruses, Human; Antineoplastic Agents, Alkylating; Apoptosis; Bone Neoplasms; Carcinoma, Squamo | 2001 |
[Flow cytometry for testing chemosensitivity of malignant bone tumors].
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neop | 1999 |
[Successful treatment of adenocarcinoma of the lung with bone metastases by combined chemotherapy with epirubicin, mitomycin C and carboplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Epirubi | 1992 |
[Hepatocellular carcinoma with a complete remission of bone metastasis achieved by arterial chemotherapy].
Topics: Bone Neoplasms; Carcinoma, Hepatocellular; Humans; Injections, Intra-Arterial; Iodized Oil; Liver Ne | 1990 |
Concurrent radiation and chemotherapy in vulvar carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone | 1989 |
Etoposide and mitomycin-C in pretreated metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Etopo | 1989 |
[Bone metastasis in advanced breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Calcitonin; Cyclop | 1987 |
[Bone metastasis from renal cell carcinoma].
Topics: Bone Neoplasms; Carcinoma, Renal Cell; Combined Modality Therapy; Humans; Kidney Neoplasms; Mitomyci | 1987 |
[Advanced gastric cancer with DIC and multiple bone metastasis treated with surgical resection and chemotherapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Co | 1987 |
Age and dose of chemotherapy as major prognostic factors in a trial of adjuvant therapy of osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation. French Bone Tumor Study Group.
Topics: Adolescent; Adult; Aging; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Com | 1988 |
[A cancer of unknown primary site with diffuse metastasis to the bone marrow treated effectively with FAM combination chemotherapy].
Topics: Anemia, Myelophthisic; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Marrow; | 1988 |
Adriamycin, vinblastine and mitomycin C as second-line chemotherapy in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Breast Neo | 1986 |
[Effective postoperative chemotherapy of gastric cancer associated with disseminated carcinomatosis of the bone marrow].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Marrow; | 1985 |